ANL 23.76 Decreased By ▼ -0.39 (-1.61%)
ASC 16.20 Decreased By ▼ -0.38 (-2.29%)
ASL 22.35 Increased By ▲ 0.20 (0.9%)
BOP 8.22 Decreased By ▼ -0.03 (-0.36%)
BYCO 8.93 Decreased By ▼ -0.14 (-1.54%)
FCCL 18.51 Decreased By ▼ -0.24 (-1.28%)
FFBL 24.90 Increased By ▲ 1.60 (6.87%)
FFL 17.93 Decreased By ▼ -0.08 (-0.44%)
FNEL 8.48 Decreased By ▼ -0.22 (-2.53%)
GGGL 22.30 Decreased By ▼ -0.45 (-1.98%)
GGL 43.50 Increased By ▲ 0.20 (0.46%)
HUMNL 6.85 Decreased By ▼ -0.13 (-1.86%)
JSCL 20.14 Decreased By ▼ -0.01 (-0.05%)
KAPCO 38.02 Decreased By ▼ -0.18 (-0.47%)
KEL 3.57 Increased By ▲ 0.02 (0.56%)
MDTL 3.07 Decreased By ▼ -0.13 (-4.06%)
MLCF 37.10 Decreased By ▼ -1.68 (-4.33%)
NETSOL 154.15 Increased By ▲ 2.10 (1.38%)
PACE 6.14 Decreased By ▼ -0.08 (-1.29%)
PAEL 31.40 Decreased By ▼ -0.40 (-1.26%)
PIBTL 9.38 Decreased By ▼ -0.11 (-1.16%)
POWER 8.05 Decreased By ▼ -0.19 (-2.31%)
PRL 21.15 Decreased By ▼ -0.29 (-1.35%)
PTC 10.60 Increased By ▲ 0.05 (0.47%)
SILK 1.54 Decreased By ▼ -0.04 (-2.53%)
SNGP 43.35 Decreased By ▼ -0.85 (-1.92%)
TELE 23.23 Decreased By ▼ -1.07 (-4.4%)
TRG 167.25 Increased By ▲ 1.00 (0.6%)
UNITY 34.72 Decreased By ▼ -0.93 (-2.61%)
WTL 3.12 Decreased By ▼ -0.09 (-2.8%)
BR100 4,974 Decreased By ▼ -23.92 (-0.48%)
BR30 24,216 Decreased By ▼ -150.3 (-0.62%)
KSE100 46,717 Decreased By ▼ -174.62 (-0.37%)
KSE30 18,560 Decreased By ▼ -43.13 (-0.23%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
26,938
7324hr
Pakistan Cases
1,212,809
2,71424hr
4.78% positivity
Sindh
446,840
Punjab
416,901
Balochistan
32,658
Islamabad
103,293
KPK
169,429

WHO approves China’s Sinopharm vaccine for emergency use

  • WHO gave emergency use listing to Beijing's Sinopharm Covid-19 vaccine, making it the sixth overall, and the first Chinese vaccine to receive WHO validation for safety, efficacy, and quality.
Updated 07 May 2021

The World Health Organization (WHO) on Friday approved the Sinpoharm vaccine for emergency use against the Covid-19. With this development, Sinopharm became China’s first coronavirus vaccine to get the WHO’s nod for international use.

Addressing a press conference in this regard, the WHO’s director-general, Tedros Adhanom Ghebreyesus said:

“This afternoon, WHO gave emergency use listing to Beijing's Sinopharm Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy, and quality.”

The other five emergency use vaccines to get WHO listings are made by Pfizer-BioNTech, Moderna, Johnson, and Johnson, and the AstraZeneca being produced at separate sites in India and in South Korea.

The approval means that Sinopharm will be included in Covax, the UN health agency’s global initiative that is designed to promote equitable vaccine distribution around the world.

According to an AFP, the Sinopharm vaccine being used in 42 territories around the world, is the fourth behind AstraZeneca (166), Pfizer-BioNTech (94), and Moderna (46).

Besides China, it is being used in Algeria, Cameroon, Egypt, Hungary, Iraq, Iran, Pakistan, Peru, the United Arab Emirates, Serbia, and Seychelles, among others.

It is a developing story, will be updated accordingly.

Comments

Comments are closed.